IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive: In brief, our study identified a novel feedback mechanism between Icsbp and Stat5 in CML that potentially increased pro-leukemia effects of Stat5 and decreased leukemia suppression by Icsbp (Figure 7).